Cxcl1 modulates MDSC infiltration in prostate tumors [35] and rhabdomyosarcomas [26], is a prognostic marker of poor outcome in breast cancer [36] and promotes metastasis in an MDA-MB-231 breast cancer xenograft model [18]. The gene discussed is CXCL1; the disease is prostate neoplasm.